If you go to festivals or out clubbing with any regularity, you’re likely all too familiar with the high-pitched ringing that can linger in your ears for days afterwards. The condition, medically known as tinnitus, can be a real problem, with the ringing reaching problematic levels while coming hand in hand with significant hearing loss. Some of us––particularly those with a tendency to get as close to the speakers as possible––will suffer from it for the rest of our lives.
That is, unless Sonormed have something to do with it. Their new app is called Tinnitracks, and they claim it can restore an equilibrium in your hearing to reduce discomfort caused by tinnitus. Tinnitracks uses software that allegedly targets the brain instead of the ear to lessen the negative effects of tinnitus.
Here’s how it works: First, a victim of tinnitus has to get a prescription from their doctor, certifying that they have a legit case of the condition. Patients then pick some of their favorite tunes and send them to Sonormed, who remove the frequencies in the music that cause the condition and send the tunes back to you. All you have to do is listen to them a bunch of times. This is said to re-wire your brain to focus on different wavelengths.
Yeah, it sounds weird, but if all it takes is a cell phone and some mp3s to reduce tinnitus discomfort, we’re willing to give it a try. Are they sure this works with techno, though?
Tech blog Labiotech explain the process more thoroughly: “Your sense of hearing is able to quickly adapt to this unfamiliar input. This systematically changed input can cause the brain to re-shift its imbalance between excitatory and inhibitory nerve signals in the auditory centre, back towards a healthy balance between the two.”
This methodology is inspired by neuro-acoustic research conducted by medical faculty at the Institute for Biosignal Analysis and Biomagnetism at the University of Münster, and it’s said to have a success rate of up to 50%. Although not yet available in the United States, Sonormed recently opened an office in Boston, Massachusetts, and are looking to pass FDA regulations to make it to the American medical market.